University of Iowa
Iowa City, Iowa, 52242, United States
NCT Number: NCT03776747
The main purpose of this study is to assess and test the reproducibility and results of hyperpolarized 3-Helium gas as a contrast agent with Magnetic Resonance Imaging (MRI) of the lungs in healthy adult subjects.
Looking for future studies?
Notify Me18 year–90 year
All sexes
Interventional
Phase 4
Iowa City, Iowa, 52242, United States
New CT imaging techniques often expose the patient to higher doses of radiation. There is a great deal of concern about effects of medical radiation exposure on the general public and regulations are becoming stricter on the radiation doses that are allowed.
One novel procedure that has been developed to evaluate the function and structure of the lung is the use of hyperpolarized gases with MRI scanners. We want to compare the lung imaging techniques that we have developed in our lab to a technique that uses hyperpolarized 3-Helium gas with MRI. This technique is free from radiation and less invasive than many lung imaging techniques.
Hyperpolarized gas MRI is based on the introduction of spins into the lungs, allowing imaging to take place. The use of hyperpolarized 3-Helium has a few advantages:
and 4) the speed of depolarization lets us measure the partial pressure of oxygen and associated gas exchange mechanisms.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Hyperpolarized gas used as a contrast agent to test reproducibility of MRI of the lungs/Images done while subject is prone.
Other names: Prone MRI scan with contrast
Hyperpolarized gas used as a contrast agent to test reproducibility of MRI of the lungs/Images done while subject is supine.
Other names: Supine MRI scan with contrast
Pre and post spirometry, diffuse lung carbon monoxide (DLCO), lung volumes
Initial scan to determine placement
Time frame: Through study completion, measurements completed at one day visit only.
Validate the intrinsic variability of ADC (cm2/s) as a function of normal procedural and physiological changes in an attempt to standardize the use of the biomarker in future assessments of pulmonary pathologies.
Eric A. Hoffman
Other
Repeatability in Hyperpolarized 3-Helium Magnetic Resonance Imaging
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05269108
Calculi, Female Urogenital Diseases
Cairo, Egypt
View Trial DetailsNCT04139096
Disease Attributes, Disease Susceptibility
Villejuif, Val de Marne, France
View Trial DetailsNCT04670016
Brain Diseases, Brain Neoplasms
Calgary, Alberta, Canada
View Trial DetailsNCT06233578
Radiation Exposure
New York, United States
View Trial Details